ARAX Capital Partners’ Post

Insights from our journey at biocrates ✨   Recently I shared biocrates' transformative journey and our vision for the future of health with Insights Care magazine. I wanted to express my conviction of the critical role metabolomics plays in reshaping the landscape of diagnostics and personalized medicine.   Motivated by our passion for sustainable health and innovation, the team at biocrates is pushing metabolomics to become a key part of daily health assessments advancing "4P medicine" – prediction, prevention, personalization, and participation. We not only contribute to the integration of metabolomics into labs worldwide and offer a supportive community for data interpretation, but also want to advance modern medicine.   Our mission is to democratize metabolomics and making standardized technology accessible to a broader audience. Whether seasoned scientist familiar with LC-MS and metabolomics or new to these fields, our ready-to-use kits and innovative software are designed to empower individuals and contribute to better insights into physiological processes.   I want to thank the biocrates life sciences ag team and our investors MIG Capital and ARAX Capital Partners for making this journey possible. I invite you to join us on seeking new possibilities in the integration of metabolomics into healthcare.   If you want to read the whole interview: https://lnkd.in/dwESaMmh For more on our vision visit: https://lnkd.in/dZrmUwdQ   #Metabolomics #Research #Vision #Health